Inovio and Collaborators Receive NIH Grant to Evaluate HIV Immunotherapy PENNVAX®-GP’s Ability to … – GuruFocus.com
|
Inovio and Collaborators Receive NIH Grant to Evaluate HIV Immunotherapy PENNVAX®-GP’s Ability to …
GuruFocus.com Development of Inovioâs PENNVAX-GP immunotherapy, which widely targets multiple major clades of HIV â providing global coverage â has been funded through a $25 million NIAID contract awarded to Inovio and its collaborators. In addition, Inovio and its … |
|
Inovio and Collaborators Receive NIH Grant to Evaluate HIV Immunotherapy PENNVAX®-GP’s Ability to …
GuruFocus.com Development of Inovioâs PENNVAX-GP immunotherapy, which widely targets multiple major clades of HIV â providing global coverage â has been funded through a $25 million NIAID contract awarded to Inovio and its collaborators. In addition, Inovio and its … |
Globalnews.ca |
The hidden treasure in your kids’ baby teeth; are stem cells worth saving?
Globalnews.ca WATCH ABOVE: When a child loses a tooth, chances are it ends up with the tooth fairy or in the trash. But as Su-Ling Goh explains, there’s a hidden treasure in the teeth that could play a role in solving future health problems. |
Philly.com |
Inovio Pharmaceutical’s DNA vaccine will be tested in patients with HIV
Philly.com Inovio’s immunotherapy, Pennvax GP, will be tested in HIV-positive patients to see if it generates killer T cells in the body’s immune system to attack the HIV virus. Current antiviral drugs work well against HIV, “but people have to take these drugs … Immune Check Activators Market — Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024Medgadget (blog) |